BSG
BioSig Tech
Stock
Stock
ISIN: US09073N3008
Ticker: BSGM
US09073N3008
BSGM
Price
Price
CHART BY
Frequently asked questions
What is BioSig Tech's market capitalization?
The market capitalization of BioSig Tech is $141.60M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for BioSig Tech?
BioSig Tech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.623. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for BioSig Tech's stock?
Currently, 1 analysts cover BioSig Tech's stock, with a consensus target price of $10.00. Analyst ratings provide insights into the stock's expected performance.
What is BioSig Tech's revenue over the trailing twelve months?
Over the trailing twelve months, BioSig Tech reported a revenue of $26.00K.
What is the EBITDA for BioSig Tech?
BioSig Tech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$12.28M. EBITDA measures the company's overall financial performance.
What is the free cash flow of BioSig Tech?
BioSig Tech has a free cash flow of -$4.56M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does BioSig Tech have, and what sector and industry does it belong to?
BioSig Tech employs approximately 5 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of BioSig Tech's shares?
The free float of BioSig Tech is 18.89M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $141.60M
- EPS (TTM)
- -$0.623
- Free Float
- 18.89M
- Revenue (TTM)
- $26.00K
- EBITDA (TTM)
- -$12.28M
- Free Cashflow (TTM)
- -$4.56M
Pricing
- 52W span
- $0.40$14.11
Analyst Ratings
The price target is $10.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.
- Employees
- 5
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US09073N3008
- Primary Ticker
- BSGM
Fundamentals & EOD data from FactSet